Fri, Aug 29, 2014, 1:07 AM EDT - U.S. Markets open in 8 hrs 23 mins

Recent

% | $
Quotes you view appear here for quick access.

Osiris Therapeutics, Inc. Message Board

  • scottmayhew2000 scottmayhew2000 Jul 23, 2013 1:07 PM Flag

    MAPCs and MSC

    Does anyone have any opinion or research (or a good site to read up on) the differences, pros and cons, of each type of stem cell approach? The MAPCs are getting a nice little write up on Seeking Alpha in relation to Athersys' approach to Crohns as opposed to Osiris'.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • FYI: Simponi trumps both for this indication.

      You want to be in Osiris for GvHD and biosurgery and Athersys for stroke and some other indications.

      SIMPONI® is indicated in adults with moderately to severely active ulcerative colitis for inducing and maintaining clinical response, improving endoscopic appearance of the mucosa during induction, inducing clinical remission, and achieving and sustaining clinical remission in induction responders, who have demonstrated corticosteroid dependence or who have had an inadequate response to or failed to tolerate oral aminosalicylates, oral corticosteroids, azathioprine, or 6-mercaptopurine.

      Sentiment: Strong Buy

 
OSIR
14.15+0.03(+0.21%)Aug 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.